These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11323380)

  • 1. Composition of CO(2) absorbents.
    Mazze RI
    Anesth Analg; 2001 May; 92(5):1356-7. PubMed ID: 11323380
    [No Abstract]   [Full Text] [Related]  

  • 2. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption.
    Neumann MA; Laster MJ; Weiskopf RB; Gong DH; Dudziak R; Förster H; Eger EI
    Anesth Analg; 1999 Sep; 89(3):768-73. PubMed ID: 10475323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.
    Struys MM; Bouche MP; Rolly G; Vandevivere YD; Dyzers D; Goeteyn W; Versichelen LF; Van Bocxlaer JF; Mortier EP
    Anaesthesia; 2004 Jun; 59(6):584-9. PubMed ID: 15144299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide.
    Stabernack CR; Brown R; Laster MJ; Dudziak R; Eger EI
    Anesth Analg; 2000 Jun; 90(6):1428-35. PubMed ID: 10825335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems.
    Murray JM; Renfrew CW; Bedi A; McCrystal CB; Jones DS; Fee JP
    Anesthesiology; 1999 Nov; 91(5):1342-8. PubMed ID: 10551585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo.
    Kharasch ED; Powers KM; Artru AA
    Anesthesiology; 2002 Jan; 96(1):173-82. PubMed ID: 11753018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of sevoflurane from a closed breathing system.
    Vagts DA; Lockwood GG
    Anaesthesia; 1997 Jul; 52(7):636-9. PubMed ID: 9244020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.
    Keijzer C; Perez RS; de Lange JJ
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of carbon monoxide production by inhalational agents.
    Coppens MJ; Versichelen LF; Rolly G; Mortier EP; Struys MM
    Anaesthesia; 2006 May; 61(5):462-8. PubMed ID: 16674622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide production from desflurane, enflurane, halothane, isoflurane, and sevoflurane with dry soda lime.
    Wissing H; Kuhn I; Warnken U; Dudziak R
    Anesthesiology; 2001 Nov; 95(5):1205-12. PubMed ID: 11684991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of inhalational anaesthetics with CO2 absorbents.
    Baum JA; Woehlck HJ
    Best Pract Res Clin Anaesthesiol; 2003 Mar; 17(1):63-76. PubMed ID: 12751549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global warming potential of inhaled anesthetics: application to clinical use.
    Ryan SM; Nielsen CJ
    Anesth Analg; 2010 Jul; 111(1):92-8. PubMed ID: 20519425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
    Mchaourab A; Arain SR; Ebert TJ
    Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desflurane and sevoflurane. New volatile anesthetic agents.
    Clarke KW
    Vet Clin North Am Small Anim Pract; 1999 May; 29(3):793-810, viii. PubMed ID: 10332823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inhalation anesthetics].
    Conzen P; Nuscheler M
    Anaesthesist; 1996 Aug; 45(8):674-93. PubMed ID: 8967581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
    Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical factors affecting the production of carbon monoxide from anesthetic breakdown.
    Woehlck HJ; Dunning M; Raza T; Ruiz F; Bolla B; Zink W
    Anesthesiology; 2001 Mar; 94(3):453-6. PubMed ID: 11374605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperatures in soda lime during degradation of desflurane, isoflurane, and sevoflurane by desiccated soda lime.
    Laster MJ; Eger EI
    Anesth Analg; 2005 Sep; 101(3):753-757. PubMed ID: 16115987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic aspects of carbon monoxide formation from volatile anesthetics.
    Baxter PJ; Garton K; Kharasch ED
    Anesthesiology; 1998 Oct; 89(4):929-41. PubMed ID: 9778011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia].
    Förster H; Behne M; Warnken UH; Asskali F; Dudziak R
    Anaesthesist; 2000 Feb; 49(2):106-12. PubMed ID: 10756964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.